The World Health Organization said Friday that two existing treatments dramatically reduced deaths from Ebola and should be given to people of all ages suffering from the often-fatal haemorrhagic disease.
Aug 19, 2022
0
22
Do patients with prolonged infections contribute to the emergence of new SARS-CoV-2 variants? A research team from the Leibniz Institute of Virology (LIV) and the University Medical Center Hamburg-Eppendorf (UKE) has investigated ...
Aug 17, 2022
0
125
COVID-19 is anticipated to keep causing regular outbreak waves for the foreseeable future. The recent COVID-19 waves have caused fewer hospitalizations and deaths than the initial ones, which is largely due to the immunity ...
Aug 8, 2022
0
81
The "living with COVID" strategy being pursued by many countries relies heavily on two key pillars. First, that vaccines continue to protect most people from severe disease. And second, that where they don't, people will ...
Aug 3, 2022
0
63
At West Boca Medical Center, Dr. Cory Harlow sees patients coming into the emergency department with many of the same symptoms they complained of during the early days of COVID in Florida: pneumonia, high fever and shortness ...
Aug 1, 2022
0
141
Australia is currently in its third omicron wave (second if you live in Western Australia). This one is caused by the subvariants BA.4 and BA.5.
Jul 20, 2022
0
45
With COVID case numbers expected to rise in Australia over the coming weeks and months there is significant concern the numbers of severely sick patients may overwhelm hospitals.
Jul 19, 2022
0
34
The antidepressant drug fluvoxamine and the gout drug colchicine are not recommended for patients with mild or moderate COVID-19 because there is currently insufficient evidence that they improve important outcomes for patients, ...
Jul 13, 2022
0
82
To put the COVID-19 pandemic in the rearview mirror and prevent other coronaviruses from causing havoc, the world needs an arsenal of measures to prevent and treat these infections. To develop new medications, researchers ...
Jul 13, 2022
0
47
A monoclonal antibody treatment taken by patients hospitalized with COVID-19 did not improve recovery time but did reduce deaths, according to a study published July 8 in The Lancet Respiratory Medicine.
Jul 11, 2022
0
139
